The medical polymer industry has garnered $17,842.5 million revenue, and it is ascribed to the expansion of the pharmaceutical sector, led by worldwide rising healthcare expenditure. 

North America holds a 41.8% industry share. The U.S.-based industry captures a substantial revenue share, led by the rising penetration of healthcare facilities, and advanced medical technology. 

Therefore, the U.S. government is highly investing in the well-being of the geriatric population, and specially-abled people. For instance, the government has proposed an investment of $ 400 billion in home and community services. 

Another major element that fuel the industry growth in the countries is presence of major medical-grade plastics manufacturers and suppliers in the industry. 

Europe is the next significant shareholder in the industry, it is ascribed to rising political support, and beneficial reimbursment policies for medical devices. In addition, the advancements in the medical device directives of the region, are projected to improve the effectiveness, medical products safety, and innovation potential of medical products. Thus, the demand for improved medical devices is projected to rise, and fuel the industry growth.

Medical polymers are massively used in the manufacturing of medical devices, surgical instruments and others, which has resulted in the expansion of healthcare industry, and fuelled the polymer requirement. 

Healthcare industry players are focusing on improving their portfolio to remain on the competitive edge. In addition, over the years, issues in the worldwide supply chains have resulted in manufacturers of medical devices to set up new production facilities.